1. Factors associated with virological success with raltegravir-containing regimens and prevalence of raltegravir-resistance-associated mutations at failure in the ARCA database† 
S. Rusconi, P. Vitiello, F. Adorni, B. Bruzzone, A. De Luca, V. Micheli, P. Meraviglia, R. Maserati, M. Di Pietro, G. Colao, G. Penco, A. Di Biagio, G. Punzi, L. Monno, M. Zazzi 
Clinical Microbiology and Infection 
Volume 19, Issue 10, Pages (October 2013)
DOI: /
Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

2. Fig. 1
(a, b) Kaplan–Meier curves describing virological response: (a) genotypic sensitivity score (GSS) estimation; (b) weighted-GSS estimation.
Clinical Microbiology and Infection  , DOI: ( / )
Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

3. Fig. 2
(a, b) Receiver operating characteristic (ROC) curve analyses for (a) genotypic sensitivity score (GSS) and (b) weighted-GSS (W-GSS). Both scores were evaluated at different cut-offs (1, 1.5, and 2).
Clinical Microbiology and Infection  , DOI: ( / )
Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions